A citation-based method for searching scientific literature

Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar, G Johan Offerhaus, Roger McLendon, B Ahmed Rasheed, Yiping He, Hai Yan, Darell D Bigner, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie, Gregory J Riggins, Kenneth W Kinzler, Bert Vogelstein, Ralph H Hruban, Anirban Maitra, Nickolas Papadopoulos, Alan K Meeker. Science 2011
Times Cited: 668







List of co-cited articles
1199 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
Yuchen Jiao, Chanjuan Shi, Barish H Edil, Roeland F de Wilde, David S Klimstra, Anirban Maitra, Richard D Schulick, Laura H Tang, Christopher L Wolfgang, Michael A Choti,[...]. Science 2011
37

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
366
31

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Jeremy Schwartzentruber, Andrey Korshunov, Xiao-Yang Liu, David T W Jones, Elke Pfaff, Karine Jacob, Dominik Sturm, Adam M Fontebasso, Dong-Anh Khuong Quang, Martje Tönjes,[...]. Nature 2012
29

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
308
28

Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors.
Ilaria Marinoni, Anja Schmitt Kurrer, Erik Vassella, Matthias Dettmer, Thomas Rudolph, Vanessa Banz, Fabio Hunger, Silvan Pasquinelli, Ernst-Jan Speel, Aurel Perren. Gastroenterology 2014
247
26

Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
David Clynes, Clare Jelinska, Barbara Xella, Helena Ayyub, Caroline Scott, Matthew Mitson, Stephen Taylor, Douglas R Higgs, Richard J Gibbons. Nat Commun 2015
148
23

Whole-genome landscape of pancreatic neuroendocrine tumours.
Aldo Scarpa, David K Chang, Katia Nones, Vincenzo Corbo, Ann-Marie Patch, Peter Bailey, Rita T Lawlor, Amber L Johns, David K Miller, Andrea Mafficini,[...]. Nature 2017
421
20

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
259
20

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
899
20

Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres.
Peter W Lewis, Simon J Elsaesser, Kyung-Min Noh, Sonja C Stadler, C David Allis. Proc Natl Acad Sci U S A 2010
514
20

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
595
19

Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors.
Aatur D Singhi, Ta-Chiang Liu, Justin L Roncaioli, Dengfeng Cao, Herbert J Zeh, Amer H Zureikat, Allan Tsung, J Wallis Marsh, Kenneth K Lee, Melissa E Hogg,[...]. Clin Cancer Res 2017
107
17

ATRX and DAXX: Mechanisms and Mutations.
Michael A Dyer, Zulekha A Qadeer, David Valle-Garcia, Emily Bernstein. Cold Spring Harb Perspect Med 2017
79
20

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
15

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
15

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
15

Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival.
Joo Young Kim, Jacqueline A Brosnan-Cashman, Soyeon An, Sung Joo Kim, Ki-Byung Song, Min-Sun Kim, Mi-Ju Kim, Dae Wook Hwang, Alan K Meeker, Eunsil Yu,[...]. Clin Cancer Res 2017
63
22

Distinct factors control histone variant H3.3 localization at specific genomic regions.
Aaron D Goldberg, Laura A Banaszynski, Kyung-Min Noh, Peter W Lewis, Simon J Elsaesser, Sonja Stadler, Scott Dewell, Martin Law, Xingyi Guo, Xuan Li,[...]. Cell 2010
814
14

ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner.
Martin J Law, Karen M Lower, Hsiao P J Voon, Jim R Hughes, David Garrick, Vip Viprakasit, Matthew Mitson, Marco De Gobbi, Marco Marra, Andrew Morris,[...]. Cell 2010
273
14

Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.
Arvind Dasari, Chan Shen, Daniel Halperin, Bo Zhao, Shouhao Zhou, Ying Xu, Tina Shih, James C Yao. JAMA Oncol 2017
13

Break-induced telomere synthesis underlies alternative telomere maintenance.
Robert L Dilley, Priyanka Verma, Nam Woo Cho, Harrison D Winters, Anne R Wondisford, Roger A Greenberg. Nature 2016
218
13

Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors.
Rachel Litman Flynn, Kelli E Cox, Maya Jeitany, Hiroaki Wakimoto, Alysia R Bryll, Neil J Ganem, Francesca Bersani, Jose R Pineda, Mario L Suvà, Cyril H Benes,[...]. Science 2015
267
13

ATRX represses alternative lengthening of telomeres.
Christine E Napier, Lily I Huschtscha, Adam Harvey, Kylie Bower, Jane R Noble, Eric A Hendrickson, Roger R Reddel. Oncotarget 2015
89
14

Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.
Shinichi Yachida, Efsevia Vakiani, Catherine M White, Yi Zhong, Tyler Saunders, Richard Morgan, Roeland F de Wilde, Anirban Maitra, Jessica Hicks, Angelo M Demarzo,[...]. Am J Surg Pathol 2012
299
12

Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.
T R Yeager, A A Neumann, A Englezou, L I Huschtscha, J R Noble, R R Reddel. Cancer Res 1999
508
12

DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Jeremy D Henson, Ying Cao, Lily I Huschtscha, Andy C Chang, Amy Y M Au, Hilda A Pickett, Roger R Reddel. Nat Biotechnol 2009
282
12

Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors.
Roeland F de Wilde, Christopher M Heaphy, Anirban Maitra, Alan K Meeker, Barish H Edil, Christopher L Wolfgang, Trevor A Ellison, Richard D Schulick, I Quintus Molenaar, Gerlof D Valk,[...]. Mod Pathol 2012
114
11

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
11

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
312
11



ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup.
Chang S Chan, Saurabh V Laddha, Peter W Lewis, Matthew S Koletsky, Kenneth Robzyk, Edaise Da Silva, Paula J Torres, Brian R Untch, Janet Li, Promita Bose,[...]. Nat Commun 2018
79
13

Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin.
Harikleia Episkopou, Irena Draskovic, Amandine Van Beneden, Gaëlle Tilman, Marina Mattiussi, Matthieu Gobin, Nausica Arnoult, Arturo Londoño-Vallejo, Anabelle Decottignies. Nucleic Acids Res 2014
107
11

Genomic footprints of activated telomere maintenance mechanisms in cancer.
Lina Sieverling, Chen Hong, Sandra D Koser, Philip Ginsbach, Kortine Kleinheinz, Barbara Hutter, Delia M Braun, Isidro Cortés-Ciriano, Ruibin Xi, Rolf Kabbe,[...]. Nat Commun 2020
35
31

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.
M Falconi, B Eriksson, G Kaltsas, D K Bartsch, J Capdevila, M Caplin, B Kos-Kudla, D Kwekkeboom, G Rindi, G Klöppel,[...]. Neuroendocrinology 2016
590
10

Everolimus for advanced pancreatic neuroendocrine tumors.
James C Yao, Manisha H Shah, Tetsuhide Ito, Catherine Lombard Bohas, Edward M Wolin, Eric Van Cutsem, Timothy J Hobday, Takuji Okusaka, Jaume Capdevila, Elisabeth G E de Vries,[...]. N Engl J Med 2011
10


A survey of telomerase activity in human cancer.
J W Shay, S Bacchetti. Eur J Cancer 1997
10

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.
Yuchen Jiao, Patrick J Killela, Zachary J Reitman, Ahmed B Rasheed, Christopher M Heaphy, Roeland F de Wilde, Fausto J Rodriguez, Sergio Rosemberg, Sueli Mieko Oba-Shinjo, Suely Kazue Nagahashi Marie,[...]. Oncotarget 2012
393
10

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors.
Paloma Cejas, Yotam Drier, Koen M A Dreijerink, Lodewijk A A Brosens, Vikram Deshpande, Charles B Epstein, Elfi B Conemans, Folkert H M Morsink, Mindy K Graham, Gerlof D Valk,[...]. Nat Med 2019
71
14

SETDB1-dependent heterochromatin stimulates alternative lengthening of telomeres.
Mathilde Gauchier, Sophie Kan, Amandine Barral, Sandrine Sauzet, Eneritz Agirre, Erin Bonnell, Nehmé Saksouk, Teresa K Barth, Satoru Ide, Serge Urbach,[...]. Sci Adv 2019
38
26

ALTernative Telomere Maintenance and Cancer.
Robert L Dilley, Roger A Greenberg. Trends Cancer 2015
120
10

Alternative Lengthening of Telomeres through Two Distinct Break-Induced Replication Pathways.
Jia-Min Zhang, Tribhuwan Yadav, Jian Ouyang, Li Lan, Lee Zou. Cell Rep 2019
103
10


Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.
Eric Raymond, Laetitia Dahan, Jean-Luc Raoul, Yung-Jue Bang, Ivan Borbath, Catherine Lombard-Bohas, Juan Valle, Peter Metrakos, Denis Smith, Aaron Vinik,[...]. N Engl J Med 2011
9

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Jonathan Strosberg, Ghassan El-Haddad, Edward Wolin, Andrew Hendifar, James Yao, Beth Chasen, Erik Mittra, Pamela L Kunz, Matthew H Kulke, Heather Jacene,[...]. N Engl J Med 2017
9

RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells.
Rajika Arora, Yongwoo Lee, Harry Wischnewski, Catherine M Brun, Tobias Schwarz, Claus M Azzalin. Nat Commun 2014
214
9


Telomere maintenance by recombination in human cells.
M A Dunham, A A Neumann, C L Fasching, R R Reddel. Nat Genet 2000
656
9

ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.
Carl Koschmann, Anda-Alexandra Calinescu, Felipe J Nunez, Alan Mackay, Janet Fazal-Salom, Daniel Thomas, Flor Mendez, Neha Kamran, Marta Dzaman, Lakshman Mulpuri,[...]. Sci Transl Med 2016
135
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.